首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2567篇
  免费   159篇
  国内免费   16篇
耳鼻咽喉   26篇
儿科学   45篇
妇产科学   80篇
基础医学   244篇
口腔科学   58篇
临床医学   312篇
内科学   418篇
皮肤病学   22篇
神经病学   151篇
特种医学   196篇
外科学   344篇
综合类   63篇
一般理论   4篇
预防医学   349篇
眼科学   125篇
药学   147篇
肿瘤学   158篇
  2021年   37篇
  2020年   17篇
  2019年   44篇
  2018年   47篇
  2017年   30篇
  2016年   30篇
  2015年   45篇
  2014年   61篇
  2013年   84篇
  2012年   86篇
  2011年   111篇
  2010年   82篇
  2009年   81篇
  2008年   103篇
  2007年   98篇
  2006年   105篇
  2005年   88篇
  2004年   77篇
  2003年   76篇
  2002年   89篇
  2001年   59篇
  2000年   78篇
  1999年   74篇
  1998年   37篇
  1997年   38篇
  1996年   40篇
  1995年   32篇
  1994年   25篇
  1993年   22篇
  1992年   45篇
  1991年   46篇
  1990年   47篇
  1989年   44篇
  1988年   35篇
  1987年   37篇
  1986年   37篇
  1985年   37篇
  1984年   40篇
  1983年   71篇
  1982年   64篇
  1981年   57篇
  1980年   63篇
  1979年   37篇
  1978年   36篇
  1977年   38篇
  1976年   25篇
  1974年   21篇
  1973年   18篇
  1970年   15篇
  1966年   22篇
排序方式: 共有2742条查询结果,搜索用时 15 毫秒
1.
2.
3.
Venetoclax is a promising agent in the treatment of acute myeloid leukemia (AML), though its antileukemic activity is limited to combination therapies. Mcl-1 downregulation, Bim upregulation, and DNA damage have been identified as potential ways to enhance venetoclax activity. In this study, we combine venetoclax with the dual PI3K and histone deacetylase inhibitor CUDC-907, which can downregulate Mcl-1, upregulate Bim, and induce DNA damage, as well as downregulate c-Myc. We establish that CUDC-907 and venetoclax synergistically induce apoptosis in AML cell lines and primary AML patient samples ex vivo. CUDC-907 downregulates CHK1, Wee1, RRM1, and c-Myc, which were found to play a role in venetoclax-induced apoptosis. Interestingly, we find that venetoclax treatment enhances CUDC-907-induced DNA damage potentially through inhibition of DNA repair. In vivo results show that CUDC-907 enhances venetoclax efficacy in an AML cell line derived xenograft mouse model, supporting the development of CUDC-907 in combination with venetoclax for the treatment of AML.  相似文献   
4.
5.
6.
7.
A multitarget PCR was developed for the direct detection of penicillinase-producing Neisseria gonorrhoeae (PPNG). The assay was validated by testing 342 PPNG isolates and 415 clinical samples. The method is suitable for routine detection of PPNG strains. Its multitarget approach reduces the potential for false-negative results caused by sequence variations.  相似文献   
8.
9.
10.
BackgroundPatients with coronavirus disease 2019 (COVID-19) have a high prevalence of detectable troponin and myocardial injury. In addition, a subset of patients with COVID-19 has detectable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral loads. The objective of this study was to understand the relationship among SARS-CoV-2 viremia, detectable troponin, and myocardial injury in hospitalized patients with COVID-19.MethodsSARS-CoV-2 plasma viral load was measured in plasma samples drawn from patients hospitalized for COVID-19 at 2 academic medical centers. Baseline characteristics and clinically obtained high-sensitivity cardiac troponin T (hs-cTnT) values were abstracted from the medical record. The main outcome was detectable hs-cTnT (≥6 ng/mL) and myocardial injury (hs-cTnT ≥14 ng/mL; >99th percentile for assay).ResultsA total of 70 hospitalized patients with COVID-19 were included in this study, with 39% females and median age 58 ± 17 years; 21 patients (30%) were found to have detectable SARS-CoV-2 viral load and were classified in the viremia group. Patients with viremia were significantly older than those without viremia. All of the patients with viremia (100%) had detectable troponin during hospitalization compared with 59% of patients without viremia (P = 0.0003). Myocardial injury was seen in 76% of patients with viremia and 38% of those patients without viremia (P = 0.004).ConclusionsHospitalized patients with COVID-19 with SARS-CoV-2 viremia have a significantly higher prevalence of detectable troponin and myocardial injury during their hospitalization compared with patients who did not. This first report of the relationship among SARS-CoV-2 viremia, detectable troponin, and myocardial injury in patients with COVID-19 points to additional mechanistic pathways that require deeper study to understand the complex interplay among these unique findings, cardiovascular outcomes, and mortality in COVID-19.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号